SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " treatment " 1,573 found 🔀 AI-powered Shuffle
Healthy Living with USA Health: Enlarged Prostate Treatment Options
In this Healthy Living, we talk with Troy M. Sofinowski, M.D., an Endourologist at USA Health.
Veterans' mental health challenges
For many veterans, coming home does not mean leaving the impact of military service behind. As we approach the 25th anniversary of 9/11, it is important to recognize the mental health struggles many veterans face—often without treatment. Rawle Andrews jr., executive director of the American Psychiatric Association Foundation, discusses this with Good Day Austin.
Prisma Health to host free webinar on menopause
Prisma Health is offering a free webinar on Sept. 23 to help women better understand menopause, recognize common symptoms, and explore treatment options that can improve their quality of life.
Adidas' Handball Spezial Gets a Dynamic Polka Dot Collab
Sneaker Politics and Adidas have teamed up on a brilliant Handball Spezial featuring a patchwork polka dot treatment inspired by Buddy Guy. Find out how to buy the sneaker here.
Labor Department Mental Health Insurance Guidance Seeks Balance
The Department of Labor released new guidance seeking to narrow enforcement related to gaps in how employers cover treatments for mental health and substance use disorders.
ECMO saves newborn with severe lung damage after RSV scare
At just 2 weeks old, Jocelyn Selle was flown to Sanford Children's Hospital in Sioux Falls -- the only home for ECMO treatment in the Dakotas.
Meet a Health Hero Finalist: Sharon Pervez-Khan
After her daughter Elora was diagnosed with an incurable, cancerous brain tumor, the Villanova mom made it her mission to accelerate research, funding, and life-saving treatment.
Scientists find a bone-building switch that could fight osteoporosis
An experimental compound called AP503 significantly strengthened bones in mice by activating GPR133, a receptor that boosts bone formation while slowing bone loss. Because the same treatment has also been linked to stronger muscles, researchers see intriguing potential for combating age-related decline and osteoporosis.
New Eugene facility will expand Oregon’s residential behavioral health system for youth
A 12-bed secure inpatient treatment facility in Eugene will serve youth ages 10-17 with acute behavioral health needs.
Epic v. Health Gorilla: “Working as Designed”
We’ve been on a bit of a legal bender since just before Labor Day, so let’s keep a good thing going! As predicted, Epic does not want its case against Health Gorilla consolidated with the data breach cases, so it filed a motion to vacate the conditional transfer. And because they had to explain to the Panel why this case is different, they put a good chunk of previously unseen Epic v. Health Gorilla discovery record on the public docket! Roll the tape! The Case Against Consolidation Before we get to the fun stuff, let’s do the housekeeping. Epic's motion boils down to three arguments (sorted in ascending order of how well they land): A judge has already decided this. Judge Olguin declined to relate the fraud action to another ELU case (Patterson v. UVA Health), holding that the two do not call for determination of substantially similar questions of law or fact. Epic asks the Panel to treat that (a Rule 42 ruling) as law of the case. The overlap is thin. The three common questions Health Gorilla and the Panel identified are neither numerous nor complex (the qualities the Panel looks for before centralizing). Moreover, they are outnumbered by the questions unique to each side: The breach cases turn on security architecture, notification timing, and patient-level access. The fraud action turns on false treatment attestations and breaches of the framework agreements. Consolidation costs more than it saves. 17 of 21 parties in the fraud action do not appear in a breach case. The cases are also at very different stages: Olguin has a scheduling order running through a January 2028 trial while the breach actions are much more nascent. I like the last two more than the first because they attack the basic economics of an MDL: there just may not be enough shared discovery here to justify dragging all the defendants and a relatively mature fraud case all the way to Florida. On the other hand (while I know exceedingly little about MDL and Rule 42), I have a hard time seeing why a district judge's decision about his own docket would control what the Panel does with the separate § 1407 question. I might be reading between the lines too much, but I sorta think Epic's own brief half-concedes this, framing the two provisions as "two sides of the same coin" but then adding "respectfully submit" (which is often lawyer speak for “we know this is a reach”). The Ladder Gets More Rungs Anyway, the arguments are not why you're here (aside from the lawyers, maybe). Back in June, we discussed how Epic was using the smaller defendants to build an evidentiary ladder toward Health Gorilla and Unit 387. Turns out discovery has been adding a few rungs of its own.
New outpatient clinic focused on suicide prevention opens in Burlington
University of Vermont Health held an open house last week to celebrate the opening of the Asha Clinic, which it describes as the only program in the region focused exclusively on suicide care. The clinic's work is led by Craig Bryan, an expert in suicide treatment and research.
Can AI fix health care? In the chaos of emergency rooms, the technology comes up short
CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of most other ailments.” But nowhere better illustrates the challenge facing AI than an emergency department.
Why does early treatment matter for psychotic episodes?
Early treatment for psychosis can improve recovery and challenge the idea that mental illness means a lifetime of suffering.
Bernalillo County DA highlights need for accountability and reform in juvenile crime and behavioral health
Bernalillo County District Attorney Sam Bregman addressed crime, juvenile reform and behavioral health during a speech in Albuquerque, emphasizing the importance of accountability and treatment working together.
Scientists engineer ready-to-use cancer-fighting T cells for solid tumors
T-cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, ...
Joe Biden shares health update after prostate cancer diagnosis while issuing warning to others
Joe Biden revealed his radiation treatment from last fall "worked as intended" as he urged men to discuss prostate cancer screening with their doctors.
The Villages Health’s $541 million settlement highlights the cost of ‘upcoding’
The settlement describes how The Villages Health would go back into patients' medical files months later and add diagnoses -- sometimes adding in monitoring, evaluations or treatments.
Santa Cruz to build a new type of mental health care center for youth
Serenity Smith, who lived at a residential treatment facility in Santa Cruz in 2024, drives to work in Aptos on Monday, Aug. 31. (Amaya Edwards — Santa Cruz Local/CatchLight Local) Located at: 5300 Soquel Ave., Santa Cruz, CA 95062. Call (831)540-4141. Behavioral Health Resources
Parents of San Diego mosque gunman say a mental health facility failed to heed FBI warning
LOS ANGELES (AP) — The mother of Caleb Vazquez alleges in her lawsuit that Park Mental Health Treatment of San Diego failed to intervene despite signs that her 18-year-old son posed an imminent threat to himself and others.
Youth with CF on approved treatment still face mental health issues
Youth with cystic fibrosis continue to experience mental and behavioral health concerns despite treatment with Trikafta, according to a study.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Sinclair's Criminally Obsessed to Present "Maternal Mental Health: How the Lindsay Clancy Trial Could Change Treatment" National Town Hall to Air on September 9
BALTIMORE – September 8, 2026 – Sinclair today announced a national town hall examining maternal mental health and the questions surrounding diagnosis, treatment and intervention that have been brought into focus by the Lindsay Clancy trial. Maternal Mental Health: How the Lindsay Clancy Trial Could Change Treatment will stream September 9 across Sinclair’s television station...
Scientists discover a powerful new antivenom hidden in rattlesnake blood
Researchers discovered that combinations of toxin-blocking proteins naturally found in rattlesnake blood can powerfully neutralize venom from several dangerous snake species. In lab tests, the mixtures were about 10 times more potent than a current commercial antivenom, pointing toward a new generation of nature-inspired snakebite treatments.
An administrative gap delays access to new pancreatic cancer treatment
A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
Maine cancer survivor sharing wellness, health lessons in new app
Tom McGowan of Windham is using what he learned during treatment to help better the lives of people around the world.
Americans aren't divided on health care. Washington is.
Drug pricing. Medicaid. Medicare. The ACA. Substance use treatment. On every one of these fronts, bipartisan majorities want government to do more.
Former “RHOBH” star Brandi Glanville details 18-hour IV treatments: ‘I feel like death’
“I know everyone wants to know exactly what I’m dealing with. I’m not ready to share that part just yet,” the “Real Housewives of Beverly Hills” alum wrote.
Perspective | The biggest barrier to teen mental health isn’t treatment
Explore this perspective on Alliance Health's innovative school-based partnership model for supporting student mental health.
The science behind the beauty business
Some of Europe’s industrial champions may be in retreat, but its cosmetics sector remains a global leader, buoyed by healthy demand, recognised brands and a reputation for innovation."The fact is, the science in cosmetics is better here in Europe than anywhere else in the world,” says Pierre Morvan, CEO of Technature, a private label cosmetics manufacturer located near Brest in France’s northwestern Brittany region. “You have to have good science in order to make the difference, and that is why we invest so much in research and innovation.”Across Europe, the beauty and skincare products sector supports an estimated 3.6 million jobs, including 265,000 employed directly in the industry, according to the Cosmetics Europe trade group.. Cosmetics production contributes an estimated €11 billion to the EU economy, and generated €30 billion in export revenue last year, a €400 million rise from 2024.Technature itself has a global footprint, supplying products for 1,500 brands in 65 countries. Its range of skin gels, facial masks, nail treatments and other products include natural ingredients and extracts derived from plants, such as seaweed, that are developed and refined through science-based analysis and testing.While industry projections point to sustained growth for the foreseeable future, driven by emerging economies and wider availability of exclusive brands that were once chiefly sold by high street retailers, the sector is not immune to the impact of geopolitics and trade wars. The Trump Administration’s tariff threats have dented cosmetics exports to the EU industry's largest overseas market. After the European Parliament approved the EU-US Turnberry Agreement in June, setting a 15% levy on many EU goods, the French Federation of Beauty Companies warned that “exports are falling sharply” and urged the EU to negotiate an opt-out for cosmetics.Technature’s CEO flags South Korea as an emerging competitor, partly due to its assertive marketing efforts. “I would have to say I am a little bit scared,” Morvan says, regarding the growth potential of the South Korean cosmetics industry. “This is why science and innovation are so important if Europe is to remain the leader.”With a workforce of 200, including biologists, chemists and other scientists, around 15% of Technature’s staff work in three research and development (R&D) labs. A similar number work in four quality control and assurance facilities, where science plays a crucial in ensuring product safety in a sector that is subject to the European Cosmetics Regulation.Educational exchange between industry and academiaIn recognition of Technature’s research and innovation, Morvan was selected as one of Brest’s ambassadors to Science Comes to Town (SCTT), a European initiative to strengthen communications and understanding between science and society. Brest is one of three coastal cities in the EU-funded programme, alongside Split (in Croatia) and Kiel (in Germany). From 7-11 September, Brest will host the EU TalentOn contest featuring 100 early-career researchers from across Europe.Morvan appreciates the value of engagement with educational and scientific institutions as well as the home community. For instance, Technature collaborates closely with university partners to enhance its in-house R&D. In addition, it invites students to its labs and sends its own researchers to local institutions. "We absolutely want the students to know what the industry is all about,” Morvan says, noting that seeing science in action can help young people “understand that they can do something real with science, to create something with what they are learning.” He says another important benefit: encouraging new generations of young people to consider a career in cosmetics.Community involvement also raises awareness about Technature and the skincare industry as a whole. “The public gains recognition of the innovative company that we are, and this is important for getting new customers,” Morvan says. One of its recent innovations — tiny, colourful cosmetic pearls that release skin moisturisers on application — was showcased at this year’s VivaTech event in Paris.Morvan holds a master's degree from the Brest Business School and studied animal production and biology in Brest at the University of Western Brittany (UBO), an SCTT partner, and at the University of Tours. He got his start in business in 2002, initially working on using seaweed as a raw material in the food industry before transitioning to cosmetics. Morvan has always been interested in connecting science and business, reflecting one the goals of SCTT to enhance public-private collaboration.The invitation to participate in SCTT was unexpected. “It was a surprise to get a call from the city of Brest saying that they wanted me on this programme,” Morvan recalls, adding that officials were drawn by his company’s R&D. “It's not only theory and science fundamentals. Our science is something that is applicable to the global market — and important for the community.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
Mark Walter and Magic Johnson’s Dodgers deal gets the Pablo Torre treatment
The sports investigative journalist examines Mark Walter’s Dodgers purchase, tracing financial ties involving Magic Johnson.
Scientists find breast cancer cells hiding behind protective “shields”
Researchers have mapped breast tumors in striking detail and uncovered hidden pockets of dormant cancer cells that may help explain why cancer can return after treatment. Unlike rapidly dividing cells, these quiet cells can essentially hibernate, allowing them to evade chemotherapy and reactivate later. The team found that they are often surrounded by immune cells and connective tissue cells that may act like a protective shield.
Parents of San Diego mosque gunman say a mental health facility failed to heed FBI warning
The parents of Caleb Vazquez are suing Park Mental Health Treatment of San Diego, claiming it did not act on FBI warnings about their son’s online activities relating to school shootings. The facility disputes responsibility for the teenager’s actions.
Scientists find a weak spot in one of the deadliest brain cancers
Researchers may have found a new way to weaken glioblastoma’s defenses against treatment. Blocking a protein called SET prevented tumors from forming in preclinical models, while targeting related proteins made cancer cells more vulnerable to radiation. The strategy works by restoring activity of PP2A, an enzyme that glioblastoma cells appear to suppress. Human testing will be needed to determine whether the approach is safe and effective.
Health officials warn public to avoid Shiawassee River after sewage overflow
Nearly 2 inches of rain fell within two hours, overwhelming the city's wastewater treatment plant Thursday.
ADHD UK Cannot Hide the Flawed Science Behind the Diagnosis and Its Treatment
The extensive critique of the biomedical account of ADHD and its treatment with stimulant medication has persisted for decades.
Cascadia Health opens 10-bed secure mental health treatment facility in Southeast Portland
A new secure residential treatment facility in Southeast Portland is now open, adding 10 beds for adults with serious mental illness as Oregon continues expandi
Israeli scientists find ‘multitasking’ gene controls mood and metabolism in mice
Weizmann Institute researchers find Orthopedia gene plays critical role throughout life after aiding in-utero brain development; study may help treatment of anxiety and metabolic disorders
Puerto Rico water crisis, youth marketing campaign: CT politics news
Plus: CT commemorates International Overdose Remembrance Day, new cancer treatment arrives, and officials highlight local Latino businesses.
Plain Language as Scientific Accountability: How to Communicate Science Beyond Academic Audiences
This joint UW/Fred Hutch—Penn CFAR session brings the two CFARs together in conversation around how we communicate science beyond academic audiences. This session will present examples of technical language from HIV cure, prevention, and treatment research and ask what happens when the people most affected by the science cannot easily understand what researchers are saying. […]
Armor Health and the Stark County Sheriff's Office Partner in Launching PATH Program at Stark County Jail and Celebrate First Graduates
/PRNewswire/ -- Armor Health (ArmorHealthcare.com), a national provider of correctional healthcare, has launched the Prevention, Accountability, Treatment &...
At least 5 other states join Mass. in covering transgender kids’ health care under Medicaid
The states, including half of New England, vow to cover the care after a new rule from the Trump administration will cut off federal funding for many treatments starting in October.
Prostate Health: Latest Treatments, Screening Guidelines, More
September is prostate cancer awareness month, so board-certified surgeon Dr. Cedrek McFadden stops by TODAY to share the latest in prostate cancer treatments. He talks about different types of diagnosis, how family genetics come into play, when to get screened, and more.
Motorcycle wreck in Chase County sends Topeka man to Newman Regional Health for treatment
A Topeka man suffered possibly serious injuries when his motorcycle crashed in southern Chase County early Thu...
Patient preference science is changing how we define a better treatment
As we enjoy the last days of Summer and head into September, one of the clearest shifts we are seeing across life sciences is a surge in demand for patient preference science. Some of that momentum reflects the work of Kielo Health, Sanius Health’s preference science division, led by Dr Tommi Tervonen, Chief Scientist. The question behind the science is simple but increasingly important: when treatment choices involve trade-offs, what do patients actually value most today?
‘Distressing’: East Texas Residents Struggle to Find Mental Health Services
Survey finds costs, access and timely treatment are putting people at risk.
Scientists revive coral dying from heat using live bacteria
Researchers successfully applied probiotic and postbiotic treatments for the first time in open sea to save the marine life form. The post Scientists revive coral dying from heat using live bacteria a...
In the shadow of Clancy case, U.K. treatment of postpartum psychosis wins supporters
Britain’s trailblazing maternal mental healthcare program gains attention as the serious psychological condition comes under greater scrutiny.
Seattle science powerhouses bet big on AI-designed biology
A new $95 million project could yield cancer treatments, genetic switches and plastic-eating enzymes.
Islamic Center of San Diego shooting suspect's family sues mental health facility
The family of 18-year-old Caleb Vazquez, one of the teens accused of the deadly shooting at the Islamic Center of San Diego, filed a lawsuit against Park Mental Health Treatment, where Vazquez was being treated.
UVA Health to bring comprehensive cancer services to Lynchburg
For cancer patients who currently travel to Charlottesville for treatment, UVA Health is hoping to make the journey a little easier.
Neuropsychologist finds gaps between treatment and science of ALS, dementia in her own family
For A. Campbell Sullivan, PsyD, this time it's personal. As a neuropsychologist and clinical associate professor of neurology at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases ...
How Richmond became a hub for complex medical care
The most complicated medical cases can require more than standard care, from specialized clinical teams to research-informed treatment options.
NYC Health + Hospitals/Kings County Expands Sleep Apnea Treatment with New Hypoglossal Nerve Implant Procedure
NYC Health + Hospitals/Kings County has expanded its sleep apnea treatment options with the introduction of a new procedure, the Hypoglossal Nerve
UT Health San Antonio neuropsychologist finds gaps between treatment and science of ALS, dementia in her own family
As a neuropsychologist and clinical associate professor of neurology at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, A. Campbell Sullivan, PsyD, is on the front lines daily of groundbreaking research and patient care in frontotemporal dementia and other neurodegenerative disorders.
UConn Health Minute: Precision Radiation
Advanced technology is transforming radiation therapy by making treatments more precise and personalized. In this UConn Health Minute, experts explain how a ...
UT Health San Antonio neuropsychologist finds gaps between treatment and science of ALS, dementia in her own family
Her journal article urges more support for those facing inherited neurodegenerative diseases Contact for media: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Sept. 2, 2026 – For A. Campbell Sullivan, PsyD, this time it’s personal. As a neuropsychologist and clinical associate professor of neurology at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health […]
UT Health San Antonio neuropsychologist finds gaps between treatment and science of ALS, dementia in her own family
Her journal article urges more support for those facing inherited neurodegenerative diseases Contact for media: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Sept. 2, 2026 – For A. Campbell Sullivan, PsyD, this time it’s personal. As a neuropsychologist and clinical associate professor of neurology at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health […]
Whatever happened to ... children infected with HIV due to failures in healthcare?
For years, Pakistan has seen cases of children infected with HIV due to unsafe treatment in clinics and hospitals. A current outbreak numbers hundreds of cases. Why does this problem keep occurring?
New FDNY report details 25 years of 9/11 health impacts
FDNY members in the program are entitled to free testing and treatment.
Immigration activity is taking a toll on children’s health, doctors say
Many healthcare providers report that since January 2025, they’ve seen a surge in missed pediatric appointments, delayed preventive care, and sick or injured kids going without treatment. Immigration and Customs Enforcement arrests have continued to climb — with a record 51,000 arrests in July — and experts predict continued unhealthy outcomes among children, causing collateral damage that could extend for years.
Poll: 72% of Rhode Islanders feel healthcare costs are too high; some are going without treatment
KINGSTON, R.I. – Sept. 1, 2026 – While most Rhode Islanders are satisfied with how healthcare is delivered in the state, they feel more should be done to make it more affordable to everyone, according to a new public opinion poll from researchers at the University of Rhode Island. Those high healthcare costs have led […]
Social Egg Freezing in the Spotlight: Choice, Business, or Burden?
Growing interest in egg preservation raises questions about access, affordability, informed consent, and whether workplace pressures shift reproductive responsibility onto women.
HHS Awards $77 Million to Strengthen Substance Use Prevention, Treatment, Crisis Services, and Mental Health Services
HHS, today announced on Overdose Awareness Day that it has awarded $77 million in new grant funding to strengthen substance use prevention.
Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia
Telehealth company Hims & Hers said on Monday it has begun offering branded GLP-1 weight-loss drugs and other treatments to men in Australia as it continues to expand its international business.
Aficamten shows potential to be first FDA-approved treatment for nonobstructive HCM
New data presented at ESC Congress 2026 represent a huge breakthrough for patients with nonobstructive HCM. "For the first time, we have shown clinically meaningful improvements in symptoms and exercise capacity with a treatment that targets the cause of the disease," one researcher explained.
Model Helps Scientists Build Better Protein-Degrading Therapies
A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.
One injection could keep osteoarthritis drugs working for weeks
Scientists have created an injectable gel that can remain inside arthritic joints for weeks, slowly releasing medication while also improving lubrication. The approach could make it easier to deliver disease-modifying drugs directly where they are needed while limiting exposure elsewhere in the body.
High Fertility Costs Push Americans Abroad For IVF Treatment
By LJ Dawson and KFF Health News HealthDay ReportersMONDAY, Aug. 31, 2026 (HealthDay News) — In the summer of 2024, Emilie and Justin Solomon found themselves on a top-secret mission in Greece. Their family and friends thought the adventure-loving couple was on another jet-setting vacation, but they ...
North Carolina: Rabid baby goats at a mobile petting zoo prompts health warning
On Friday, the North Carolina Department of Health and Human Services reported confirmed multiple rabies cases in baby goats at a mobile petting zoo located in Iredell County. They were first notified of a potential rabies exposure among four baby goats at Farm Adventures in Harmony, North Carolina on August 27. The goats were most likely exposed to rabies by a skunk that had entered the pen where they were kept in late July. The NC State Laboratory of Public Health confirmed rabies viruses in three of the baby goats on August 28; a fourth goat was not tested but is also assumed to have been infected. Based on information gathered on August 28, it was determined that no other animals on the farm pose a risk of rabies exposure to people. Learn about rabies Anyone who had contact with baby goats from the Farm Adventures mobile petting zoo either at their location in Harmony, North Carolina, or at an off-site event, between July 28 and Aug. 27, 2026, may have been exposed while the animals were infectious. Impacted individuals should contact their local health department to determine whether medications are needed to prevent infection. Individuals are encouraged to call before visiting an emergency department or urgent care clinic to determine if treatment is needed and where it can be accessed. Known potential exposure dates and locations include: July 28: Jurney’s Assisted Living, 1942 Van Haven Drive, Statesville in Iredell County July 30: Private event in Mecklenburg County Aug. 1: Community Connections Back-to-School Bash, Breeden Amphitheater, 333 S. Main St., Lexington in Davidson County Aug. 6: Brookdale Peachtree, 2806 Peachtree Road, Statesville in Iredell County Aug. 8: Private event in Watauga County Aug. 9: Private event in Burke County Aug. 15: Masonic Picnic Grounds, 201 Poplar St., Mocksville in Davie County Aug. 16: Private event in Durham County Aug. 22: Private event in Iredell County Aug. 23: Private event in Durham County Rabies is a deadly disease that can spread from wild animals to pets and people, primarily through a bite, scratch or when infected saliva touches broken skin or mucous membranes. Human rabies infections are extremely rare in the United States. No human cases have been reported in North Carolina since 2011. Rabies is almost always fatal in mammals, including people, unless medications to prevent infections are given before symptoms develop. Symptoms can begin weeks to months after someone is exposed. Early symptoms are flu-like illness including weakness, fever or headache as well as a prickling or itching sensation where someone was bitten or exposed. In 2025, over 4,000 animals were submitted to the NC State Laboratory of Public Health for rabies testing, and of these, approximately 6% tested positive. In North Carolina the disease most often occurs in wild animals especially skunks, raccoons, bats and foxes. Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
EU provides €12 million to WHO to sustain essential health services and support recovery across Syria
30 August 2026, Damascus, Syrian Arab Republic – The World Health Organization (WHO) has received €12 million (approximately US$14 million) from European Union Humanitarian Aid, to help sustain essential health...
I’m a mental health expert. Here’s how I would search for an online therapist.
Online treatment can be just as effective as traditional in-person visits, but certain strategies can help ensure the best outcome.
Public health alert: Sewage spill contaminates Arkansas River downstream of Pueblo
Health officials are warning the public to avoid the Arkansas River downstream of Pueblo – until further notice – after a “significant accidental release” of untreated sewage from the city of Pueblo’s wastewater treatment plant last week was found to have contaminated the water with high levels of E.coli. “The contaminated water will move downstream, […]
Clinical trial participation playing key role in advancing science
Clinical trials, whether for new cancer treatments or simple lifestyle interventions, are based on foundational science and lots of planning.
In Southeast Minnesota, clinical trial participation plays a key role in advancing science
Clinical trials, whether for new cancer treatments or simple lifestyle interventions, are based on foundational science and lots of planning.
Healthcare executive’s mansion gets star treatment in the national real-estate press
Now that the kids are in college, Rod and Linda Windley are looking to sell their not-so-little piece of heaven in Sandy Springs, Ga., for $18.25 million.
An Experimental Single-Time Treatment Slashed Cholesterol for a Year
A small gene-editing study significantly reduced LDL cholesterol levels, and the results have stuck a year later.
How A Tribal Health System Built A Wastewater Early-Warning System From Scratch
Tribal health org in remote Alaska proved wastewater surveillance can detect flu, RSV, and COVID-19 days before clinical cases in underserved communities.
Brain scan method may improve diagnosis, treatment of psychosis
Vanderbilt Health study identifies two previously unreported subtypes of psychosis based on an analysis of structural brain scans.
Cross-border collaboration crucial for Shaw Prize laureates’ cancer breakthrough
Three winners in life science and medicine honoured for joint efforts to understand and develop treatment for acute promyelocytic leukaemia.
Smart nanoparticles light up brain cancer and destroy what surgery misses
Scientists created smart nanoparticles that can both illuminate hidden glioblastoma cells during surgery and destroy microscopic cancer left behind afterward. In mice, the treatment prevented recurrence and led to 100% survival at 60 days, though it has not yet been tested in humans.
Health Brief: The hidden costs of the surprise billing fix
Plus: The FDA approves pioneering treatment for one of the deadliest cancers.
3 Quality Behavioral Health Locations Raided by FBI and Michigan Law Enforcement
Three of Michigan-based Quality Behavioral Health's addiction treatment facilities were raided by the FBI and local law
Scientists may have found a shortcut to calorie restriction’s anti-aging benefits
Moderate calorie restriction lowered an immune protein called C3 that appears to help drive chronic inflammation as the body ages. Blocking the same protein reduced age related inflammation in mice, raising the possibility that future treatments could mimic some benefits of calorie restriction without severe dieting.
When it comes to women’s health, money talks
Women's health experts suggest a 'reverse pitch' approach to endometriosis, osteoporosis, and autoimmune treatments, stressing the profit potential.
Perez Hilton 'lucid' after mental health crisis, brother-in-law says
Perez Hilton's brother-in-law shared that the gossip blogger was in a “lucid” state and after receiving treatment for his physical injuries.
Perez Hilton is 'lucid' after mental health crisis, brother-in-law shares
Perez Hilton's brother-in-law shared that the gossip blogger was in a "lucid" state and after receiving treatment for his physical injuries.
How IHH Healthcare CEO Prem Kumar Nair is planning for a longer-lived Asia
The head of Asia’s largest private health group is advancing clinical longevity, cancer care, AI and neighborhood-based treatment.
Addiction Treatment Providers Navigate Rising Federal Scrutiny on Fraud
As the federal government continues to put a microscope on behavioral health spending, substance use disorder providers are more focused than ever on
FBI raids drug rehab centers in Detroit, Troy, Eastpointe
The FBI raided three Quality Behavioral Health centers in metro Detroit that bills itself as a "One Stop Center for Addiction treatment"
Coating stops tooth decay in children
A clinical trial found that a topical treatment called silver diamine fluoride stops cavities in young children from getting worse.
From Diagnoses to Treatments, Why Americans Use AI Chatbots for Health
Americans use chatbots for a host of health-related reasons, from helping make diagnoses on their own to learning more about information they may have gotten from a doctor. Nearly all chatbot health users find this AI information helpful.
Stroke-related imaging costs have tripled in recent years, despite declining reperfusion rates
A new analysis has revealed an unexpected relationship between stroke-related imaging volumes and the use of IVT and EVT treatments.
New USF Health clinic coordinates care for children with allergic diseases
Providers evaluate patients, discuss complex cases, and develop treatment plans for overlapping conditions.
Gov. Reeves Announces Investment In Mental Health Services For Mississippi Youth » Office of Governor Tate Reeves
Gov. Tate Reeves today announced the state of Mississippi is deploying $3,375,709 to support expanded mental health services for children, adolescents and young adults who were negatively affected by the COVID-19 pandemic. Through the Community Development Block Grant CARES Act Coronavirus Relief (CDBG‑CV) program, the Mississippi Development Authority has approved targeted funding to modernize treatment environments and establish new programming focused on long-term recovery.
Spiraling health costs force Iranians to delay care
A single chemotherapy session in Iran can cost six times the monthly minimum wage. As drug prices soar and medicine is in short supply, doctors say more patients are delaying or abandoning treatment.
Browns Put on Notice Over Treatment of Deshaun Watson
The Cleveland Browns are facing criticism following Deshaun Watson's postgame meltdown. The post Browns Put on Notice Over Treatment of Deshaun Watson appeared first on HEAVY.
BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
—First-in-Disease and First-in-Class Therapy Approved in Japan for Patients With Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage—...
SUN: Maryland launches court-ordered mental health treatment program
Health officials are launching a controversial program to help those with severe mental health challenges adhere to their treatment by using a court order.
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential
False narratives could undermine public confidence in an important tool that may help prevent or treat cancer in the future.
Congo receives more than 16,000 doses of Ebola vaccine as it grapples with unprecedented outbreak
The current Ebola outbreak in Congo is caused by the rare Bundibugyo virus, which currently has no approved treatment or vaccine.